Advertisement

Topics

The Society of Memorial Sloan-Kettering Cancer Center Company Profile

14:50 EDT 25th May 2016 | BioPortfolio


News Articles [5309 Associated News Articles listed on BioPortfolio]

Seres Therapeutics forms research collaboration with Memorial Sloan Kettering Cancer Center

Seres Therapeutics, a microbiome therapeutics platform company, today announced that it has entered into a strategic, multi-year research collaboration with Memorial Sloan Kettering Cancer Center (MSK...

MSK studies highlight potential of liquid biopsy at San Antonio Breast Cancer Meeting

(Memorial Sloan Kettering Cancer Center) Information gleaned from a liquid biopsy may help predict how individual women with advanced breast cancer will respond to certain therapies as well as reveal ...

Value Framework Guidelines

In recent years, a number of organizations have developed value frameworks to assess new treatments.  These organizations include the Institute for Clinical and Economic Review (ICER), Memorial Sloan...

Gritstone gets exclusive rights from Memorial Sloan Kettering

Gritstone Oncology licensed exclusive global rights to IP, research data, bioinformatics tools, and know-how from Memorial Sloan Kettering Cancer pertaining to the development of tumor-specific neo-an...

Seres Therapeutics Announces Broad Agreement with Memorial Sloan Kettering Cancer Center to ...

Read more...

The World-Renowned Memorial Sloan Kettering Cancer Center in New York City uses a Renishaw inVia Confocal Raman Microscope, in the Kircher Laboratory, to Support the Development of Nanomolecular Probes

The Kircher laboratory at Memorial Sloan Kettering is developing novel nanoprobes for molecular imaging, image-guided therapy and theranostics. Its ultimate goal is to develop a universal technology ...

Hunter Douglas Creates Fellowship for Breast Cancer Research at Memorial Sloan Kettering

PEARL RIVER, N.Y., May 25, 2016 /PRNewswire/ -- Hunter Douglas, the leading manufacturer of custom window fashions in North America, has established the Hunter Douglas Fellowship in Breast C...

Hybrid cancer drug could be resistance-resistant

A team of cancer researchers led by scientists at UC San Francisco and Memorial Sloan Kettering Cancer Center demonstrated in human cells and mouse models that a first-of-its-kind hybrid drug can outs...

PubMed Articles [10135 Associated PubMed Articles listed on BioPortfolio]

Overview: New Modality for Cancer Treatment.

Cancer immunotherapy is now becoming a promising modality of cancer treatment upon the clinical successes of adoptive T-cell transfer and immune checkpoint blockade. At the 30th Nagoya International C...

Translational Bioinformatics and Clinical Research (Biomedical) Informatics.

Translational bioinformatics and clinical research (biomedical) informatics are the primary domains related to informatics activities that support translational research. Translational bioinformatics ...

Associations of immunity-related single nucleotide polymorphisms with overall survival among prostate cancer patients.

The progression of prostate cancer is influenced by systemic inflammation, and may be attributed, in part, to genetic predisposition. Single nucleotide polymorphisms associated with the immune respons...

Efficacy and safety of sorafenib versus sunitinib as first-line treatment in patients with metastatic renal cell carcinoma: largest single-center retrospective analysis.

We conducted this largest, single-center, retrospective study to determine the efficacy of sorafenib versus sunitinib as first-line therapy for metastatic renal cell carcinoma (mRCC) in Chinese patien...

Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC.

To report on the influence of ophthalmic artery chemosurgery (OAC) on enucleation rates, ocular and patient survival from metastasis and impact on practice patterns at Memorial Sloan Kettering for chi...

Clinical Trials [5487 Associated Clinical Trials listed on BioPortfolio]

Measurement of Cancer-Related Risk Perception in Smokers

The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Cen...

Acute Normovolemic Hemodilution Versus Standard Intraoperative Management in Patients Having Hepatic Resection and Pancreaticoduodenectomy

With a major liver or pancreas operation, there is a chance that one will require a transfusion of blood products (either red blood cells or plasma). This may be necessary during the oper...

Collection of Tissue, Blood, and Cells to Be Used For Studying the Causes, Prevention, Diagnosis, and Treatment of Breast Cancer

The purpose of this study is to collect a blood sample from patients with breast disease (cases) and from individuals without breast cancer (controls)that may be used for research purposes...

A Randomized Study of Sulindac in Oral Premalignant Lesions

The purpose of this study is to see if a drug called sulindac can prevent the development of changes in the mouth that are related to oral pre-cancer growths (oral epithelial dysplasia) or...

Behavioral Intervention For BMT/SCT Survivors

The purpose of this study is to understand how to help survivors of bone marrow transplant and stem cell transplant (BMT/SCT) with emotional distress. BMT/SCT has become a more common type...

Companies [3296 Associated Companies listed on BioPortfolio]

Memorial Sloan-Kettering Cancer Center

Memorial Sloan-Kettering Cancer Center's tradition of care began more than 100 years ago. In 1884, the cornerstone of the New York Cancer Hospital -- what was later to become Memorial Hospital for Can...

The Society of Memorial Sloan-Kettering Cancer Center

Memorial Sloan Kettering Cancer Center

The CMO’s Structure, Assets, and Goals

Optimer Pharmaceuticals

Optimer's core competence includes the development of innovative drugs for treating diseases that currently have no satisfactory therapy. These include antibiotics for drug-resistant bacterial infecti...

Mojave Therapeutics Incorporated

Mojave Therapeutics is building a new class of biopharmaceuticals that primes the immune system to fight cancer and viral diseases. Mojave’s core technologies, developed by leading researchers at Me...

More Information about "The Society of Memorial Sloan-Kettering Cancer Center" on BioPortfolio

We have published hundreds of The Society of Memorial Sloan-Kettering Cancer Center news stories on BioPortfolio along with dozens of The Society of Memorial Sloan-Kettering Cancer Center Clinical Trials and PubMed Articles about The Society of Memorial Sloan-Kettering Cancer Center for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Society of Memorial Sloan-Kettering Cancer Center Companies in our database. You can also find out about relevant The Society of Memorial Sloan-Kettering Cancer Center Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record